Sam Slutsky
Stock Analyst at LifeSci Capital
(2.94)
# 1,341
Out of 5,172 analysts
3
Total ratings
66.67%
Success rate
83.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sam Slutsky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PVLA Palvella Therapeutics | Initiates: Outperform | $90 | $112.50 | -20.00% | 1 | Aug 4, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Outperform | $45 → $101 | $120.34 | -16.07% | 1 | Jul 23, 2025 | |
| IFRX InflaRx | Upgrades: Outperform | n/a | $0.94 | - | 1 | Apr 5, 2023 |
Palvella Therapeutics
Aug 4, 2025
Initiates: Outperform
Price Target: $90
Current: $112.50
Upside: -20.00%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Outperform
Price Target: $45 → $101
Current: $120.34
Upside: -16.07%
InflaRx
Apr 5, 2023
Upgrades: Outperform
Price Target: n/a
Current: $0.94
Upside: -